Black diamond therapeutics stock forecast
WebMar 17, 2024 · BDTX Earnings Date 2024 Black Diamond Therapeutics Earnings Forecast Positive News Sentiment NASDAQ:BDTX Black Diamond Therapeutics - BDTX Earnings Date, Estimates & Call Transcripts $1.63 -0.04 (-2.40%) (As of 03/17/2024 12:00 AM ET) Compare Today's Range $1.60 $1.70 50-Day Range $1.35 $3.14 52-Week … WebIf you're new to stock investing, here's how to buy Black Diamond Therapeutics stock. What is BDTX's forecast return on assets (ROA) for 2024-2026? (NASDAQ: BDTX) …
Black diamond therapeutics stock forecast
Did you know?
WebDec 30, 2024 · Pre-Market Most Active for Jan 11, 2024 : BDTX, SQQQ, FTI, QQQ, AAL, TQQQ, F, NOK, RIO, AAPL, SAN, PLTR Nasdaq.Com • Jan 11, 2024 How Many Black Diamond Therapeutics, Inc.... WebStock Price Forecast. The 3 analysts offering 12-month price forecasts for Black Diamond Therapeutics Inc have a median target of 3.00, with a high estimate of 16.00 …
WebMar 24, 2024 · The 2 analysts offering price forecasts for Black Diamond Therapeutics have a median target of 7.00, with a high estimate of 10.00 and a low estimate of 4.00. The median estimate represents... WebBased on 3 Wall Street analysts offering 12 month price targets for Black Diamond Therapeutics in the last 3 months. The average price target is $9.00 with a high …
WebJul 15, 2024 · Black Diamond Therapeutics' stock was trading at $1.80 at the beginning of the year. Since then, BDTX stock has increased by 5.0% and is now trading at $1.89. View the best growth stocks for 2024 here. According to the issued ratings of 2 analysts in the last year, the consensus rating for … Web1 day ago · Company Profile. Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery of small molecule, tumor-agnostic therapies. …
WebLinked companies : Black Diamond Therapeutics, Inc. Summary Presently, Julie Seidel occupies the position of Investor Relations Contact at Black Diamond Therapeutics, Inc.
WebMar 9, 2024 · The Company’s proprietary Mutation-Allostery-Pharmacology, or MAP drug discovery engine, is designed to allow Black Diamond to analyze population-level genetic sequencing data to identify oncogenic mutations that promote cancer across tumor types, aggregate these mutations into families, de-orphaning oncogenic mutations and develop … joiner apprenticeshipWebJan 16, 2024 · Black Diamond Therapeutics has a market capitalisation of US$96m and burnt through US$88m last year, which is 91% of the company's market value. That suggests the company may have some funding difficulties, and we'd be … joiner and lookup differenceWebMay 19, 2024 · The PK data for the BDTX-189 QD regimen demonstrated dose-dependent increases in exposure up to 800 mg QD, achieving the predicted efficacious exposure at 800 mg QD. BDTX-189 was rapidly absorbed,... how to help children with impulsive adhdWebApr 11, 2024 · Undisclosed program development candidate nomination anticipated in 2024. $122.8 mm in cash, cash equivalents and investments as of December 31, 2024. Cash … joiner and raynard constructionWebBlack Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update. On track to provide clinical update from dose-escalation … joiner and builder blackpoolWeb17 hours ago · Analysts Offer Insights on Healthcare Companies: Black Diamond Therapeutics (BDTX) and Pliant Therapeutics (PLRX) 03/10/23-5:40AM EST TipRanks Black Diamond Therapeutics GAAP EPS of -$0.59 beats ... joiner apprenticeship burnleyWebMar 17, 2024 · Stock Lists Headlines About NASDAQ:BDTX Black Diamond Therapeutics - BDTX Insider Trading & Ownership $1.63 -0.04 (-2.40%) (As of 03/17/2024 12:00 AM ET) Compare Today's Range $1.60 $1.70 50-Day Range $1.35 $3.14 52-Week Range $1.18 $4.08 Volume 33,834 shs Average Volume 136,027 shs Market Capitalization $59.46 … joiner anderson statesboro ga